Delivers 2x increase in AAV titers compared to market alternates. Reduce plasmid input, halve the bioreactors, and significantly lower cost per dose. HORSHAM, Pa. — In a groundbreaking step toward advancing gene therapy manufacturing, Kyfora Bio launched KyFect™ – AAV, a next-generation transfection reagent designed specifically for high-yield, scalable viral titers. As recombinant adeno-associated virus (AAV)-based therapies lead […]
AAA Biotech added more recombinant proteins to their catalog to broaden the scope of biomedical research. Available with custom solutions and worldwide delivery. LA JOLLA, CA — With a collection of over 600 recombinant antibodies, AAA Biotech is the global leader in providing the highest quality research reagents. The company announces more additions of rProteins to […]
Melbourne, Australia and New York, NY — OnQ Software, developer of the modern cloud-based Laboratory Information Management System (LIMS) platform QLIMS, and Basepair Inc., a leading provider of cloud-based bioinformatics analysis solutions, today announced a strategic partnership to streamline end-to-end genomic workflows in sequencing laboratories worldwide. Today’s genomics labs must navigate a patchwork of separate […]
New software release simplifies GMP validation of in-house NGS-based assays, enabling faster and more accurate assessment of critical quality attributes in cell and gene therapy. Basel, Switzerland — Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Selector®. This end-to-end solution automates […]
Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS® (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test as a […]
Believes Years of Self-Inflicted Issues Have Caused Avantor to Trade at a Meaningful Discount to its Intrinsic Value and Life Sciences Peers Contends the Board Has Failed to Remedy Operating Underperformance, Ineffective Cost Controls and Poor Capital Deployment – Resulting in Significant Value Destruction Over Every Relevant Period Makes Clear the Board Needs to Be […]
Lebanon, NH – Bio X Cell, the global leader of functional antibody solutions for translational studies, is proud to announce the appointment of Biogene India as its exclusive distributor in India. Established in 1995, Biogene India is trusted by research institutions across India to provide quality life-science research products. Headquartered in New Delhi and led by industry veteran Sanjay Makhija, […]
Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today issued the following statement in response to the […]
Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for NanoSpark® activation products Joint development of new solutions for cell and gene therapy markets Sartorius Stedim Biotech enters into minority shareholding Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, and Nanotein Technologies, a developer of next-generation […]
Acquisition Will Further Expand Chromium’s Capabilities PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive agreement to acquire Scale Biosciences, Inc., a leader in innovative and scalable single cell analysis. The acquisition provides 10x with key inventions and technologies that will advance innovation […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
